Hautarztpraxis Dr. Mihaescu
- Address
- lock Available on a paid plan
Hautarztpraxis Dr. Mihaescu - Atopic Dermatitis Research Center
Hautarztpraxis Dr. Mihaescu is a specialized dermatology research center with focused expertise in moderate-to-severe atopic dermatitis clinical trials. The practice demonstrates extensive experience in evaluating novel biologic therapies and maintains strong capabilities in both adult and adolescent patient populations, with particular emphasis on long-term safety and efficacy assessments.
- Novel biologic therapies including rezpegaldesleukin and amlitelimab for moderate-to-severe atopic dermatitis
- Maintenance therapy studies evaluating optimal dosing regimens and treatment withdrawal protocols
- Long-term safety monitoring and efficacy evaluation in atopic dermatitis patients
- Combination therapy approaches with background topical corticosteroids
The center's research portfolio reflects comprehensive involvement across all phases of atopic dermatitis treatment development, from initial efficacy studies to extended follow-up trials. Their participation in multiple interconnected studies, including parent trials and long-term extension protocols, demonstrates capability in managing complex study designs and maintaining patient continuity throughout treatment development programs.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 43 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 42 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautarztpraxis Dr. Mihaescu
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis | Almirall S.A. | Phase III | Not Recruiting | May 2023 | Apr 2026 |
IMP list
lock Showing 1 of 43 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 4 | Unknown | 2022-11-10 | 2024-10-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.